| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LENZ Therapeutics, Inc. | Director | Common Stock | 620,599 | $28,907,501 | $46.58 | 07 Nov 2025 | By trust |
| LENZ Therapeutics, Inc. | Director | Common Stock | 10,500 | $239,278 | $22.79 | 07 Nov 2025 | Direct |
| LENZ Therapeutics, Inc. | Director | Stock Option (right to buy) | 13,500 | 11 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | 07 Nov 2025 | 1 | +$239,278 | 4 | Director | 10 Nov 2025, 16:13 |
| LENZ | LENZ Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 11 Jun 2025, 17:46 |
| LENZ | LENZ Therapeutics, Inc. | 13 May 2024 | 1 | +$501,093 | 4 | Director | 14 May 2024, 17:29 |
| LENZ | LENZ Therapeutics, Inc. | 21 Mar 2024 | 5 | +$249,992 | 4 | Director | 25 Mar 2024, 20:42 |
| LENZ | LENZ Therapeutics, Inc. | 21 Mar 2024 | 0 | $0 | 3 | Director | 25 Mar 2024, 20:26 |